Conversations on Twitter :
@FierceBiotech: In case you missed it last week, check out our 2012 Fierce 15 report: Report | BPA 2012 Slideshow | Follow @FierceBiotech
@JohnCFierce: One of the two nucs Vertex licensed from Alios ($60M/$1.5B) turned out to be a dud. The other one is headed for PhII. Vertex release | Follow @JohnCFierce
@RyanMFierce: My interview with Daphne Zohar on how Appeering distills smart banter in biotech from the Twitter hose. Story | Follow @RyanMFierce
> With an eye to building a biotech industry, the Saudis have invested $93 million in R&D, with a special focus on chemistry and nanotechnology. The numbers were reviewed at the Saudi International Biotechnology Conference in Riyadh. Story
> Dendreon ($DNDN) has outlined its plans to ax 145 of its workers in Seattle, including a number of R&D jobs. The job losses are part of the biotech company's earlier announced restructuring following disappointing results for Provenge. Story
> Clarus Therapeutics reports that its oral testosterone replacement therapy--CLR-610--achieved its primary endpoint in a Phase III study. Release
> The diagnostic company Nodality has hired Laura Brege, the former Onyx ($ONXX) COO, as its new chief executive officer. Report
> Hemispherx reports that the FDA has scheduled a panel review for Ampligen, which had earlier been rejected by the agency. The company's shares slid on the news. Story
> Following a 9-month delay, Cellceutix reports that it's ready to launch a Phase I study of its lead cancer drug. Report
Pharma News
@FiercePharma: J&J Hid Risks Risperdal Makes Boys' Breasts Grow: Lawyer--Bloomberg. Report | Follow @FiercePharma
> Reckitt to pull Suboxone tabs in favor of on-patent film version. News
> Stada lightens payroll load by 385 with Russian sell-off. More
> French arm-twisting prompts Sanofi to slash job-cuts target. Story
@FierceMedDev: Abbott Labs is launching its dissolvable coronary stent in Europe, Asia and Latin America. Release | Follow @FierceMedDev
@MarkHFierce: Bad breath bacteria could be a pancreatic cancer clue. More | Follow @MarkHFierce
@DamianFierce: Frost & Sullivan says devicemakers must adjust to new pricing pressures to stay afloat. More | Follow @DamianFierce
> Analysts: Devicemakers need to adapt to new economic reality. Article
> Apnex Medical snags $10M for apnea device. News
Pharma Manufacturing News
@EricPFierce: Special report from FierceVaccines.com : 20 Top-selling Vaccines -- H1 2012. Report | Follow @EricPFierce
> Stada sells 2 plants in Russia. News
> Omkar expands its India API production. Article
Biotech Research News
> Roche, AstraZeneca lung cancer Rx beat Alzheimer's in fruit flies and mice. Article
> Constellation gains $7.5M to advance preclinical blood cancer drug. More
> Roswell Park researchers spot versatile cancer treatment. Story
> Natural killer cells may be key to lung cancer susceptibility. Item
And Finally… Some currently used cancer drugs proved effective against a pair of animal models for Alzheimer's. Release